Shareholding disclosure

Thea Paola + Francesco Angelini

Declared position

9.391%

Threshold

Crossed upwards

Timeline

Published

18.08.2026

Transaction

15.07.2026

Voting rights breakdown

Voting rights acquired9.391%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

ZA01-000000000SHE0

Beneficial owner

Thea Paola + Francesco Angelini

Declared address

Thea Paola + Francesco Angelini, Rome, IT

Catalyst Pharmaceuticals, Inc. was acquired by Angelini Pharma S.p.A.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Thea Paola + Francesco Angelini

Santhera Pharmaceuticals Holding AG18.08.2026ZA01-000000000SHE0

Disclosure summary

Thea Paola + Francesco Angelini disclosed a holding in Santhera Pharmaceuticals Holding AG on the acquisition side, published by SIX Exchange Regulation on 18.08.2026, at 9.391% of voting rights. Notice category: Single shareholder.

Disclosed position

9.391%

Voting rights acquired

Voting rights acquired9.391%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Thea Paola + Francesco Angelini disclosed a holding in Santhera Pharmaceuticals Holding AG, published on 18.08.2026.

Publication date18.08.2026

Transaction date15.07.2026

Issuing companySanthera Pharmaceuticals Holding AG

Beneficial ownerThea Paola + Francesco Angelini

Declared addressThea Paola + Francesco Angelini, Rome, IT

CategorySingle shareholder

Voting rights acquired9.391%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDZA01-000000000SHE0

Conditions

Catalyst Pharmaceuticals, Inc. was acquired by Angelini Pharma S.p.A.

Source: SIX Exchange Regulation · Publication date: 18.08.2026

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open